SCHEMBL8200256

SCHEMBL8200256

O=C(Nc1cccnc1)c1ccc2c(c1)CCC(CCN1CCC(c3ccccc3)CC1)C2=O

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 5/20 0.47
ALDH1A1 P00352 6/20 0.45
HTR2C P28335 2/20 0.45
SMN1; SMN2 Q16637 4/20 0.43
MAPK1 P28482 3/20 0.43
LMNA P02545 2/20 0.43
USP2 O75604 1/20 0.43
TSHR P16473 1/20 0.43
MAPT P10636 3/20 0.42
MEN1 O00255 1/20 0.41
POLB P06746 1/20 0.41
KMT2A Q03164 1/20 0.41
ACHE P22303 1/20 0.41
KDM4E B2RXH2 1/20 0.41
GAA P10253 1/20 0.41
ITGB3 P05106 2/20 0.41
ITGA2B P08514 2/20 0.41
CCR5 P51681 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8204772 0.92 HTR2C (0.50) HTR2CACHEITGB3ITGA2BCCR5
SCHEMBL8192524 0.91 HTR2C (0.47) ALDH1A1HTR2CLMNAMAPTACHE
SCHEMBL8201273 0.88 HTR2C (0.48) HTR2CLMNAMAPTACHEITGB3
SCHEMBL8199033 0.87 HTR2C (0.46) HTR2CACHEITGB3ITGA2B
SCHEMBL8198493 0.86 MAPT (0.47) ALDH1A1HTR2CLMNAMAPTPOLB
SCHEMBL8198779 0.85 HTR2C (0.47) HTR2CACHEITGB3ITGA2BCCR5
SCHEMBL8200675 0.83 HTR2C (0.49) ALDH1A1HTR2CMEN1KMT2A
SCHEMBL8198980 0.82 HTR2C (0.55) HTR2C
SCHEMBL8204780 0.82 ACHE (0.44) HTR2CACHEITGB3ITGA2BCCR5
SCHEMBL8204778 0.82 ACHE (0.44) HTR2CACHEITGB3ITGA2BCCR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6048877-A Tetralone derivatives as antiarrhythmic agents BRISTOL-MYERS SQUIBB COMPANY (US) 2000-04-11 US claimed
US-6048877-A Tetralone derivatives as antiarrhythmic agents BRISTOL-MYERS SQUIBB COMPANY (US) 2000-04-11 US disclosed